I don't know where Amy is on vacation, but in addition to being a type 1 diabetic she reported in a tweet months ago she is a celiac. FYI in case that detail has been omitted.
harden1_colton, I can almost always determine English-as-a-second-language posters due to their incorrect use of prepositions. Although American English is my mother tongue, I do speak a European second language fluently. Prepositions are by far the most difficult grammar to manage no matter how fluent one is in a second language.
docfrezza, why won't you respond to my question about any orals you may have prescribed for your Type 2 patient? I asked about metformin or other oral drugs you might prescribed. I am very interested in prior oral drug history.
djjanke2003, the borrow rate at Fidelity has been 30.75% for about a week. It still is right now.
almannforpresident, I read your inputs since May 11, and I wonder with your Afrezza results are you looking to stop your Metformin and Byetta? With Afrezza as a type 2 you may not need them anymore.
kittybearrn, i happened to have saved the "almost unbelievable" topic post from doctor.stockpicker on another site, unfortunately not as the text but as the web address. When i retrieve it now it shows, "This topic is deleted.". The 31 short troll handle owners (about 3 people collectively) clearly got together and claimed abuse. The Yahoo bot did the rest.
Read this to understand what can happen when a Novolog or Humalog dose is guessed at incorrectly. This blogger spent all evening trying to correct a severe low that would not go away for hours and hours. She was ingesting sugary foods for hours and hours. httpscolon//goodotgl/0xBBbi She blogs out of Australia, but she was at ADA2015 and says likely moving to New York. Hard to imagine why she is not on Afrezza already.
mnkdmysavior, this will give you plenty on metformin's negatives for kidneys. httpcolon//goodotgl/Z65yl6 There are many worse side effects. Replace colon with : and replace dot with . to get to the link with the information.
mnkdmysavior, getrichtq has given you a ridiculous reply. If your husband is not a totally out of control blood sugar type 2, the basal, lantus, and the metformin are likely not needed any longer with Afrezza alone. If he really needs the basal, lantus, your husband can do the lantus along with the Afrezza at meal times. Metformin chemically forces the pancreas and other organs to do things those organs are not supposed to do. The side effects are myriad and really undesirable. Why wait until July 15 to make an appointment with another endo. You husband can tell your current endo on July 15 he is glad to hear his opinion, but he proactively got an Afrezza prescription from another doc. Those doctor ratings you cite are just like those top 10 university surveys you often see.
docfrezza, there is a type 1 poster by the name of sam on tudiabetes (not sam finta) who wrote some months ago he had very tight control of his blood glucose before he tried Afrezza. After using Afrezza he wrote to other posters there that Afrezza gave him tight control of his BG, but Afrezza freed him of lots of maintenance and thinking of his diabetes all the time. He wrote given the choice of his old diabetes pump and measuring regimen and such or using Afrezza, he chose Afrezza for the new freedom it gave him and his quality of life improvement. With Afrezza he is also now able to eat a lot more foods he likes than he could eat with is old insulin analog drugs and methods.
lakers_w, I looked up this press release from Sanofi. The actual press release title has nothing about Afrezza or Afrezza label expansion. The body of the press release does not mention Afrezza either. httpCOLON//gooDOTgl/kM6DEA
ddbikessamsara, the only place Matt/MNKD could get that kind of valid prescription information would be from Sanofi. No other company would have that kind of detail.
lotusprince, Lixilan is just a better injected basal insulin analog to try to protect Sanofi's Lantus/Toujeo business. It is nothing pertaining prandial insulin, that is, Afrezza. Also lotus, I know what you are and why you post, and I am simply posting my valid information to inform the low information readers of your original post above.
jx1960, for a stock as volatile as MNKD, it seems to me not quite enough time premium is being offered on options trades, especially longer term options. Is my observation right on this? I did look at INTC options just as a comparison to something big and not as volatile, and MNKD options do offer a few percent more time premium for strikes at or near the money. However it seemed MNKD should have offered more from market makers given the borrow and volatility. Could you comment or provide a counter input on this MNKD time premium. Thanks.
lakers_w, I personally spoke to Dr. Boss on the phone several months ago, and he had already moved over to work at Sanofi. I spoke to him on his phone at his Sanofi location.
thebattman, get a quote on Fidelity of SHAK, and you will see Fido charges borrowers 90.5% for borrowing them. They probably pay accounts that loan the shares about 80%.